spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Akorn 

 HSMN NewsFeed - 19 Aug 2022
Calyptus Pharmaceuticals Announces FDA Approval of Cetrorelix Acetate for Injection, 0.25 mg/vial
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Aug 2022
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Jun 2017
Eton Pharmaceuticals Names Sean Brynjelsen Chief Executive Officer and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2016
Akorn Launches Ibuprofen Oral Suspension
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 18 Aug 2016
Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 19 Jan 2016
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 27 Aug 2015
InSite Vision and QLT Amend Merger Agreement
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 27 Apr 2015
Akorn Announces Recent Executive Appointments
Biopharmaceuticals Generic Personnel
 HSMN NewsFeed - 9 May 2014
Akorn to Acquire VersaPharm for $440 Million
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 9 Jan 2014
Akorn Acquires Betimol(R) from Santen
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 18 Dec 2013
InSite Vision Announces Positive Confirmatory Phase 3 Results for BromSite(TM) for the Reduction of Inflammation and Pain after Cataract Surgery
Biopharmaceuticals Drug Delivery Ophthalmology Surgery
 HSMN NewsFeed - 23 May 2012
APP Pharmaceuticals Acquires Three Products from Nexus
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 21 Apr 2010
Akorn Announces FDA Approval to Re-Launch Erythromycin Ophthalmic Ointment USP 3.5 g
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 18 Dec 2009
Akorn Announces Business Update
Biopharmaceuticals
 HSMN NewsFeed - 17 Jun 2009
Akorn Acquires Capastat Sulfate from Eli Lilly and Company
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 9 Jun 2009
Akorn Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2009
Akorn Appoints Jeffrey A. Whitnell as Interim Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2008
Akorn, Inc. Announces the FDA Approval of Akten(TM) Ophthalmic Gel 3.5%
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 2 Sep 2008
Akorn-Strides, LLC Announces FDA Approvals for Dexamethasone Sodium Phosphate Injection USP, 4 mg (base)/mL and Dexamethasone Sodium Phosphate Injection USP, 10 mg (base)/mL
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Jul 2008
Akorn-Strides, LLC Announces the First Commercial Product Launch for the Joint Venture, Rifampin for Injection
Biopharmaceuticals
 HSMN NewsFeed - 23 May 2008
Akorn-Strides, LLC Announces FDA Approval for Rifampin for Injection USP, 600 mg/Vial
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Apr 2008
Akorn-Strides, LLC Announces FDA Approvals for Ondansetron Injection USP, 4 mg/2mL Single Dose Vials and Ondansetron Injection USP, 40 mg/20mL Multiple Dose Vials
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Apr 2008
Akorn, Inc. Announces FDA Approval of Diclofenac Sodium Ophthalmic Solution 0.1%
BIopharmaceuticals Generics Ophthalmology FDA
 HSMN NewsFeed - 16 Apr 2008
Akorn, Inc. Announces FDA Approval of Ofloxacin Ophthalmic Solution USP, 0.3%
Biopharmaceuticals Generics FDA Ophthalmology
 HSMN NewsFeed - 3 Apr 2008
Akorn, Inc. Signs Supply Agreement with Fresenius Kabi for Premix Product
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2008
Akorn-Strides, LLC Announces FDA Approval for Fosphenytoin Sodium Injection USP, 100 mg/2mL and 500 mg/10mL
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Jan 2008
Akorn, Inc. Announces FDA Approval of Calcitriol Injection, 1 mcg/mL and 2 mcg/mL
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Dec 2007
Akorn, Inc. Announces FDA Inspection Results
Biopharmaceuticals
 HSMN NewsFeed - 11 Oct 2007
Akorn, Inc. Signs an Exclusive Licensing, Development and Supply Agreement with Sofgen Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Oct 2007
Novadaq Resumes Normal Business Operations by Securing ICG for SPY
Devices Surgery Radiology
 HSMN NewsFeed - 27 Jul 2007
Akorn, Inc. Announces FDA Approval of Ketotifen Fumarate Ophthalmic Solution, 0.025%
Biopharmaceuticals Ophthalmology Generics FDA
 HSMN NewsFeed - 5 Jul 2007
Auriga Laboratories Appoints Rick Coulon Vice President of Consumer Brands
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2007
Akorn, Inc. Announces the New Drug Application (NDA) Filing for Akten(R)
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 8 Jun 2007
Akorn, Inc. and Natco Pharma Limited add Two Injectable Drug Products To API Supply and Margin Sharing Agreement
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2007
Akorn Inc. Names Douglas R. Pinnell As Vice President, Vaccine Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2007
Akorn, Inc. Names Shawn L. Silvestri, Ph.D. As Vice President, New Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2007
Akorn, Inc. Signs Exclusive Distribution Agreement With Massachusetts Biologic Laboratories For Tetanus Diphtheria Vaccine
Biopharmaceuticals Distribution
 HSMN NewsFeed - 30 Jan 2007
Akorn, Inc. Signs an Exclusive Supply Agreement For Hydase(TM) (Hyaluronidase Injection, USP) 150 Units/mL, an NDA Product
Biopharmaceuticals
 HSMN NewsFeed - 23 Jan 2007
Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 9 Jan 2007
Akorn, Inc. Signs Exclusive Definitive Agreement For the Development and Supply of Three Ophthalmic ANDA Drug Products
Biopharmaceuticals Ophthalmology Generics
 HSMN NewsFeed - 13 Nov 2006
Akorn, Inc. and FDC Limited Sign Exclusive Development and Supply Agreement for Two Ophthalmic Suspension Drug Products
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 24 May 2006
Akorn, Inc. Announces Product Approval for Orphenadrine Citrate Injection
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 17

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 17 additional stories matching:
Akorn
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.